Matthias Klugmann
Birkendorfer Str. 65
Biberach An Der Riss, BW 88397, Germany
Biberach An Der Riss, BW 88397, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Engineering aptamer dimers (apdimers) for optimization of synthetic riboswitches.
Journal: Nucleic acids research
Published: March 31, 2026
Spatial mapping of barcoded, brain-tropic AAVs using multiplexed RNA in situ hybridization.
Journal: Molecular therapy. Advances
Published: September 26, 2025
Preclinical development of TAK-754, a high-performance AAV8-based vector expressing coagulation factor VIII.
Journal: Molecular therapy. Methods & clinical development
Published: August 30, 2024
Vector-Free Deep Tissue Targeting of DNA/RNA Therapeutics via Single Capacitive Discharge Conductivity-Clamped Gene Electrotransfer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 13, 2024
Engineering oxypurinol-responsive riboswitches based on bacterial xanthine aptamers for gene expression control in mammalian cell culture.
Journal: Nucleic acids research
Published: May 15, 2024
Gene Electrotransfer via Conductivity-Clamped Electric Field Focusing Pivots Sensori-Motor DNA Therapeutics: "A Spoonful of Sugar Helps the Medicine Go Down".
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 06, 2024
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice.
Journal: Frontiers in immunology
Published: December 22, 2023
TRPC Channels Activated by G Protein-Coupled Receptors Drive Ca2+ Dysregulation Leading to Secondary Brain Injury in the Mouse Model.
Journal: Translational stroke research
Published: May 03, 2023
Recessive aminoacyl-tRNA synthetase disorders: lessons learned from in vivo disease models.
Journal: Frontiers in neuroscience
Published: March 09, 2023
Dominant aminoacyl-tRNA synthetase disorders: lessons learned from in vivo disease models.
Journal: Frontiers in neuroscience
Published: March 09, 2023
Dual-function AAV gene therapy reverses late-stage Canavan disease pathology in mice.
Journal: Frontiers in molecular neuroscience
Published: October 04, 2022
Last Updated: 09/26/2026